Haemonetics Corp (HAE)
95.01
+0.61
(+0.65%)
USD |
NYSE |
May 06, 09:38
Haemonetics Free Cash Flow: 128.75M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 128.75M |
| September 30, 2023 | 199.15M |
| June 30, 2023 | 175.76M |
| March 31, 2023 | 162.87M |
| December 31, 2022 | 128.11M |
| September 30, 2022 | 116.31M |
| June 30, 2022 | 87.88M |
| March 31, 2022 | 75.75M |
| December 31, 2021 | 32.73M |
| September 30, 2021 | 53.88M |
| June 30, 2021 | 52.05M |
| March 31, 2021 | 71.76M |
| December 31, 2020 | 117.61M |
| September 30, 2020 | 119.58M |
| June 30, 2020 | 119.20M |
| March 31, 2020 | 109.46M |
| December 31, 2019 | 80.62M |
| September 30, 2019 | 50.65M |
| June 30, 2019 | 39.09M |
| March 31, 2019 | 40.32M |
| December 31, 2018 | 71.92M |
| September 30, 2018 | 81.82M |
| June 30, 2018 | 116.46M |
| March 31, 2018 | 145.55M |
| December 31, 2017 | 125.99M |
| Date | Value |
|---|---|
| September 30, 2017 | 123.47M |
| June 30, 2017 | 100.09M |
| March 31, 2017 | 83.60M |
| December 31, 2016 | 89.36M |
| September 30, 2016 | 61.16M |
| June 30, 2016 | 42.67M |
| March 31, 2016 | 19.46M |
| December 31, 2015 | 28.36M |
| September 30, 2015 | 17.48M |
| June 30, 2015 | 13.31M |
| March 31, 2015 | 4.958M |
| December 31, 2014 | -7.113M |
| September 30, 2014 | 25.42M |
| June 30, 2014 | 42.22M |
| March 31, 2014 | 65.88M |
| December 31, 2013 | 59.37M |
| September 30, 2013 | 38.31M |
| June 30, 2013 | 31.08M |
| March 31, 2013 | 22.89M |
| December 31, 2012 | 25.58M |
| September 30, 2012 | 32.56M |
| June 30, 2012 | 38.90M |
| March 31, 2012 | 62.12M |
| December 31, 2011 | 64.84M |
| September 30, 2011 | 85.28M |
Free Cash Flow Range, Past 5 Years
32.73M
Minimum
Dec 2021
199.15M
Maximum
Sep 2023
101.12M
Average
109.46M
Median
Mar 2020
Free Cash Flow Benchmarks
| Stryker Corp | 2.858B |
| Becton Dickinson & Co | 3.026B |
| Boston Scientific Corp | 1.553B |
| Masimo Corp | 6.40M |
| Insulet Corp | 36.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.54M |
| Cash from Investing (Quarterly) | -268.94M |
| Cash from Financing (Quarterly) | 109.43M |
| Free Cash Flow Per Share (Quarterly) | -0.4439 |
| Free Cash Flow to Equity (Quarterly) | -131.19M |
| Free Cash Flow to Firm (Quarterly) | -21.45M |
| Free Cash Flow Yield | 2.64% |